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Abstract
Purpose. Being able to compare hospitals in terms of quality and safety between countries is important for a number of
reasons. For example, the 2011 European Union directive on patients’ rights to cross-border health care places a requirement
on all member states to provide patients with comparable information on health-care quality, so that they can make an
informed choice. Here, we report on the feasibility of using common process and outcome indicators to compare hospitals
for quality and safety in ﬁve countries (England, Portugal, The Netherlands, Sweden and Norway).
Main Challenges Identified. The cross-country comparison identiﬁed the following seven challenges with respect to compar-
ing the quality of hospitals across Europe: different indicators are collected in each country; different deﬁnitions of the same
indicators are used; different mandatory versus voluntary data collection requirements are in place; different types of organiza-
tions oversee data collection; different levels of aggregation of data exist (country, region and hospital); different levels of
public access to data exist; and ﬁnally, hospital accreditation and licensing systems differ in each country.
Conclusion. Our ﬁndings indicate that if patients and policymakers are to compare the quality and safety of hospitals across
Europe, then further work is urgently needed to agree the way forward. Until then, patients will not be able to make
informed choices about where they receive their health care in different countries, and some governments will remain in the
dark about the quality and safety of care available to their citizens as compared to that available in neighbouring countries.
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Introduction
There are many reasons why it is important to be able to
assess and compare hospitals in terms of quality and safety
both within and between countries, for example to help
hospitals improve their services and for governments to
understand the impact of their policies. As it becomes more
common for patients to seek health care in different coun-
tries [1], the need for comparative information to enable
choice is becoming more important. This has been
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recognized by the recent European Union (EU) directive on
cross-border care [2], placing responsibility on countries to
provide relevant information about the health care they
provide to help patients make a choice based on the availabil-
ity, safety and quality.
Here, we report on the challenges identiﬁed in developing
a framework of available indicators and information that
could be used to assess hospitals based on the quality and
safety in ﬁve European countries, considering the issue
involved and making recommendations for the future. The
countries are England, Portugal, The Netherlands, Sweden
and Norway; countries representing variation in important
aspects of health care, for example, funding arrangements
and health-care quality [3]. Health services research teams
working in leading universities in these countries are partici-
pating in the EU-funded Quality and Safety in European
Hospitals research study [4, 5], a study in 10 hospitals, 2 in
each country [6] exploring the organizational and contextual
factors affecting how hospitals implement quality improve-
ment. The purpose of the selection process for the study
was to ﬁnd hospitals at different stages of the quality
journey, rather than only those seen to be doing well.
Indicators available in each country to
assess and compare hospitals
Ten commonly used quality and safety process and outcome
indicators were proposed to identify hospitals with different
levels of performance in each country, indicators that are
widely regarded in the medical ﬁeld as good practice
(Table 1), including operating on hip fractures within 48 h.
The research teams were asked whether the indicators were
available; who had access; were they available for every hos-
pital; how robust were the data (including deﬁnitions); and
what other indicators were available?
Table 1 summarizes the responses received, with only
three outcome indicators available in all countries: infection
rates; a range of condition-speciﬁc mortality rates; and
Caesarean section rates and only one process indicator: hip
fractures treated in a set period. In general, these indicators
were publicly available, but in Portugal, this was more com-
plicated as described later in this paper, and in all cases, the
researchers had to know where to look for the information
from different organizations and websites.
The data for methicillin-resistant Staphylococcus aureus
(MRSA) bacteraemia were not considered to be helpful in
the Netherlands and Sweden, where the rates are very low as
compared to the UK, where this indicator is considered very
relevant and where until recently, the numbers have been
much higher. It was apparent that although available in all
countries, these indicators were not directly comparable
because of differences in deﬁnitions (Table 2). For example,
the surgical site infection rates in some countries are based
on 1 day prevalence surveys, whereas in others, surveillance
systems operate, which include every patient, and in each
country, different surgical procedures are included, some are
mandatory, whereas others are voluntary. The indicator of
hip fracture treatment ranged from operating within 18 h in
Sweden to 48 h in England and was only available for people
aged over 65 in Norway.
The following sections provide more detail by country.
England
In England, data are collected centrally from each hospital
organization through the Hospital Episode Statistics data-
base. These data are analysed by Dr Foster Intelligence (a
partnership between the UK Department of Health and a
commercial provider of health-care information), and each
year, a hospital guide is made available to the public, setting
out the position of each hospital against a range of indicators
[7]. Data on every patient with a blood stream MRSA infec-
tion are collected with aggregated ﬁgures for each hospital
made available on a public website [8].
Portugal
Since 2001, the Health Minister has provided the
Organisation for Economic Co-operation and Development
(OECD) with process and outcome indicators similar to
those in Table 1. However, it is not possible to disaggregate
the data into regions and hospitals, making individual hos-
pital comparisons impossible. In the last decade, various
reforms, such as the merger of hospitals into clusters and
changes in the mix of public–private ownership, have led to
past performance data being lost in the merged groups,
and some are only now producing group wide data.
Furthermore, hospital organizations have autonomy to
choose the processes and outcomes indicators that they use,
and these are their exclusive property. In this context, access
to good quality performance data was almost impossible in
Portugal, and the indicators included in the Performance
Evaluation Reports of Public Portuguese Hospitals [9] were
used as a proxy. These reports of raw data have been pub-
lished annually since 2005 by the National School of Public
Health [10], but are not adjusted for age or case mix.
Netherlands
In the Netherlands, there was a wealth of publicly available
data about quality in hospitals, predominantly derived from
the information of the Dutch Health Care Inspectorate
(IGZ) [11] and listed by a newspaper in an annual top 100
hospitals [12]. This is supported by further information of
the Dutch Association of Hospitals (NVZ) [13] such as hos-
pital mortality rates. Infection data are separately collected
for all hospitals, but presented in a combined way on a
health-care comparison website [14]. Process measures were
chosen from a wide range of publicly available information,
including pressure ulcers and eye examination for diabetes,
measures collected by the hospitals, but not externally
validated.
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Sweden
Sweden has a tradition of collecting data nationally; however,
more quality data have been collected over time by county
councils (who manage hospitals in Sweden) and private health
organizations. There are also many disease-speciﬁc quality
registries. One of the key issues in Sweden is that most data so
far have been published at a county council level, but there
were enough data published at a hospital level to satisfy the
needs of the project. An increasing number of hospital-speciﬁc
quality indicators are now being published, and a process is
ongoing between the Swedish Association of County Councils
and Regions [15] and the National Board of Health and
Welfare [16] to analyse and make available national information
in an accessible way and for comparative purposes.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Quality and safety indicators available in each country highlighting difference between countries
Indicator England Portugala Netherlands Sweden Norway Indicators
available in
all countries
C-diff or MRSA
rates
Yes,
available
for every
hospital
Yes Data are collected at a
national level from all
hospitals. Low rates, so
information is not used
to compare quality in
hospitals
Yes, but data are
not considered
useful to compare
hospitals because
of the low rates
Data are not
available at the
hospital level.
Surgical site
infection rates
Yes Yes Yes Yes Yes Yes
Composite
mortality rate
Yes
HSMR
Yes Yes
Potentially avoidable
mortality rate in
proportion of actual
mortality rate of the
hospital
For some hospitals,
not all
Not available in time
for this process—
now available
Speciﬁc mortality
rates (AMI,
stroke, CABG
and AAA)
Yes Yes Yes Yes Some, but not all
available in time for
this process— all
now available
Yes
Emergency
readmission rates
Within a
set period
Yes Only for heart failure
readmissions within 12
weeks
Some diagnoses,
not all
Not available
publicly (could be
requested from the
Norwegian Patient
Register for a fee)
Third and fourth
degree perineal
trauma rate
Yes No Yes, but not available at
the hospital level for
comparison (voluntary
data collection by
obstetricians)
Yes Not available in time
for this process—
now available
Caesarean
section rate
Yes Yes Yes Yes Yes Yes
Primary
angioplasty rates
Yes Yes Yes Yes No, but could be
requested from the
Norwegian Patient
Register on payment
of a fee (see above)
Hip fractures
treated in set
time
Yes Yes Yes Yes Yes Yes
24 h brain scan
rate for stroke
Yes Yes No No No
AMI, acute myocardial infarction; AAA, abdominal aortic aneurysm; CABG, coronary artery bypass graft; HSMR, hospital standardized
mortality indicator.
aIn Portugal, the information was available but was not available publicly by hospital.
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Norway
In Norway, hospital indicator data are reported by the hospi-
tals to the Norwegian Patient Register and the Norwegian
Institute of Public Health and published on a website called
‘Free Hospital Choice’[17]. The Norwegian Directorate of
Health [18] publishes data on a growing number of national
quality indicators in acute care. It is mandatory in Norway to
report MRSA infections, but this information is not available
for each hospital. The process indicators available were dif-
ferent here to other countries and included the number of
patients placed on a bed in a corridor, bathroom, laundry
room or living room at 7 a.m. and the proportion of patient
discharge letters transferred within 7 days to the general
practitioner.
Hospital accreditation or licensing
schemes in each country
Table 3 describes the hospital licensing, accreditation or
similar schemes in each country showing that this type of
information is not available to be used to assess or compare
the quality of hospital care in Europe.
Only in England is there is a statutory licensing scheme
for all hospitals [19]. In the other countries, accreditation or
certiﬁcation is voluntary, and quality award schemes are often
based on the Baldridge Award [20].
Challenges and potential solutions
These ﬁndings highlight the differences between countries in
the data and information available about the quality and safety
of hospital care. In England, the Netherlands and Norway,
various hospital data are submitted to national organizations
that conduct analysis and make them available to the public by
hospitals. In Sweden, the level of aggregation of the data is
stronger at the county council level and in the disease-speciﬁc
quality registries. In Portugal, the information that is collected
at the national level is not easy to obtain by region or hospital.
In all countries, data on speciﬁc procedures or conditions are
collected by organizations, including medical societies, but not
all make this available to the public.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Examples of differences in the deﬁnition of indicators between countries
Indicator Country Deﬁnition
Surgical site
infections
England Surveillance methodology used. Hospitals are able to choose from 14 categories of surgical
procedures. Data are collected on each patient who has a procedure in the category under
surveillance. SSIs that meet standard case deﬁnitions are identiﬁed through active follow-up
during the post-operative stay or through readmission
Netherlands Percentage of patients with post-operative site infection within 30 days after surgery with at
least one of the following symptoms: pain, redness, local swelling and heat. (based on the
deﬁnitions of European Centre for Disease Prevention and Control)
Norway The number of demonstrated hospital infections—of the four most common, urinary tract,
lower respiratory, post-operative wound and septicaemia—at a given point of time, in relation
to the total number of hospitalized patients at the same time. Post-operative wound infection
data collected for: (i) heart surgery, (ii) Caesarean section, (iii) insertion of prosthesis in the hip
joint, (iv) removal of gall bladder and (v) surgical intervention on colon
Caesarean
section rate
England,
Netherlands
and Norway
The proportion of all deliveries that were a Caesarean section
Sweden Percentage of Caesarean sections at uncomplicated delivery, age 20–34 years
Hip fractures
treated within a
set period
England The percentage of all patients with a fracture neck of femur as primary diagnoses that have a
related procedure within 2 days.
Netherlands Percentage of patients with ASA 1 & 2 classiﬁcations operated within 1 day. Also, percentage
of patients with ASA 3 & 4 classiﬁcations operated within 1 day
Sweden Percentage of hip fractures treated within 18 h of arrival at hospital
Norway Proportion of patients over 65 years with hip fracture, treated within 48 h after being
hospitalized with needs of immediate help
24 h brain scan
rate for stroke
England Proportion of stroke patients who have a brain scan (CT or MRI) performed on the day of
admission and within 1 day of admission
Netherlands Average time between the admission by TIA or Stroke and the completion of standard
diagnostic tests—blood tests, brain imaging, ECG and imaging of the neck vessels.
ASA, American society of anesthesiologists; SSIs, surgical site infections; TIA, trans ischaemic attack.
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The differences in the indicators collected by countries
highlight the different policy concerns of those countries. In
England, for example, data are available on MRSA infections
for each hospital, whereas in Norway, no MRSA hospital
level data are available, but data are available on the propor-
tion of patients placed in a bed in a corridor or living room
at 7 a.m. Each country also has a different approach to the
assessment of hospitals in terms of accreditation or licensing
with most having voluntary schemes. Only England has
statutory licensing and an ‘annual health check’ of hospitals.
Discussion/conclusions
The increasing movement of people across borders for
health care, whether by choice or circumstance, is driving the
need for more transparency about the quality and safety of
health care in European hospitals. The new EU directive on
patients’ rights [2] places a responsibility on member states to
‘provide relevant information to help individual patients to
make an informed choice, including on treatment options,
on the availability, quality and safety of the health care they
provide’[21].
In recognition of the requirement for all citizens to have
access to high-quality, safe health care, the EU has been
engaged in a number of projects to support hospitals in this
quest and to ﬁnd ways of monitoring and measuring this.
These include the SIMPATIE project [22] that reported in
2007 on the development of indicators and outcome mea-
sures and a vocabulary for patient safety across Europe. The
OECD [23] and WHO [24] have also funded projects to
develop indicators for hospital quality and safety. However,
the ﬁndings here show that despite all this important work,
there are very little data available on the quality and safety of
hospital care that is comparable between these ﬁve countries
in Europe, and we anticipate that this is likely to be the case
across the EU and in countries outside Europe, where citi-
zens also travel for health care.
In 2008, the European Observatory on Health Systems
and Policies [25] reported that the EU needs to answer the
question of how citizens of Europe can be assured that they
will receive high-quality care if they need health care beyond
their national frontiers. Both OECD [26] and the
SIMPATIE [22] project have recommended that the quality
of administrative data for health services in the EU needed
to improve. Our study indicates that to date these issues have
not been addressed and that further work is urgently needed
to ﬁnd a way forward if patients are to have any information
to make choices between health-care providers when they
travel for treatment in Europe. Clearly, the solution will need
to be of low cost with the information easily kept up-to-date.
The ﬁrst step may be for those countries without compara-
tive data about the safety and quality of their hospitals to be
required to assemble available information from hospitals
within their borders, to analyse this information and place it
in the public domain. In the longer term to provide informa-
tion for comparison between countries, the solution may be
to agree to a small set of well-deﬁned indicators to be col-
lected by each hospital organization in Europe with some
common standards and methods for assessing these.
Alternatively, the solution may be a patient-led hospital
equivalent of an internet hotel comparison website such as
‘Trip Advisor’ (www.tripadvisor.com). In the meantime,
patients travelling across the borders for their health care in
Europe will not be able to make informed choices about
where they receive their health care on any other basis than
access, and many governments in Europe will remain in the
dark about the quality and safety of care currently available
to their citizens in their hospitals as compared to that
available elsewhere.
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